AI assistant
Sending…
MACROGENICS INC — Director's Dealing 2017
Jul 27, 2017
34129_dirs_2017-07-27_b308415f-7555-44d0-bcc4-ebb6e665da35.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: MACROGENICS INC (MGNX)
CIK: 0001125345
Period of Report: 2017-07-26
Reporting Person: Bonvini Ezio (Sr VP, Research & CSO)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2017-07-26 | Common Stock | M | 26632 | $1.51 | Acquired | 120026 | Direct |
| 2017-07-26 | Common Stock | M | 26632 | $0.94 | Acquired | 146658 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2017-07-26 | Employee stock option (right to buy) | $1.51 | M | 26632 | Disposed | 2023-01-05 | Common Stock (26632.0) | Direct |
| 2017-07-26 | Employee stock option (right to buy) | $0.94 | M | 26632 | Disposed | 2022-03-13 | Common Stock (26632.0) | Direct |
Footnotes
F1: 12.5% of the options become exercisable 6 months after the date of grant and the remaining 87.5% shall vest in 14 substantially equal quarterly installments thereafter.
More from MACROGENICS INC
Declaration of Voting Results & Voting Rights Announcements
2026
May 20
Regulatory Filings
2026
May 13
Merger & Acquisition
2026
May 12
Proxy Solicitation & Information Statement
2026
Apr 8
Major Shareholding Notification
2026
Mar 27
Board/Management Information
2026
Mar 2
Regulatory Filings
2026
Feb 24
Director's Dealing
2026
Feb 18
Director's Dealing
2026
Feb 18
Director's Dealing
2026
Feb 18